KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Teva Pharmaceutical Industries (TEVA) Operating Leases (2018 - 2026)

Teva Pharmaceutical Industries filings provide 9 years of Operating Leases readings, the most recent being $280.0 million for Q1 2026.

  • On a quarterly basis, Operating Leases fell 2.78% to $280.0 million in Q1 2026 year-over-year; TTM through Mar 2026 was $280.0 million, a 2.78% decrease, with the full-year FY2025 number at $288.0 million, down 2.7% from a year prior.
  • Operating Leases hit $280.0 million in Q1 2026 for Teva Pharmaceutical Industries, down from $288.0 million in the prior quarter.
  • In the past five years, Operating Leases ranged from a high of $442.0 million in Q4 2022 to a low of $280.0 million in Q1 2026.
  • Median Operating Leases over the past 5 years was $296.0 million (2024), compared with a mean of $322.8 million.
  • Biggest five-year swings in Operating Leases: grew 6.25% in 2022 and later decreased 27.6% in 2023.
  • Teva Pharmaceutical Industries' Operating Leases stood at $442.0 million in 2022, then decreased by 27.6% to $320.0 million in 2023, then dropped by 7.5% to $296.0 million in 2024, then fell by 2.7% to $288.0 million in 2025, then fell by 2.78% to $280.0 million in 2026.
  • The last three reported values for Operating Leases were $280.0 million (Q1 2026), $288.0 million (Q4 2025), and $283.0 million (Q3 2025) per Business Quant data.